Transcription factor GATA2 may potentiate follicle-stimulating hormone production in mice via induction of the BMP antagonist gremlin in gonadotrope cells.


Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
07 2022
Historique:
received: 28 01 2022
revised: 15 05 2022
accepted: 22 05 2022
pubmed: 2 6 2022
medline: 27 7 2022
entrez: 1 6 2022
Statut: ppublish

Résumé

Mammalian reproduction depends on the gonadotropins, follicle-stimulating hormone (FSH), and luteinizing hormone, which are secreted by pituitary gonadotrope cells. The zinc-finger transcription factor GATA2 was previously implicated in FSH production in male mice; however, its mechanisms of action and role in females were not determined. To directly address GATA2 function in gonadotropes, we generated and analyzed gonadotrope-specific Gata2 KO mice using the Cre-lox system. We found that while conditional KO (cKO) males exhibited ∼50% reductions in serum FSH levels and pituitary FSHβ subunit (Fshb) expression relative to controls, FSH production was apparently normal in cKO females. In addition, RNA-seq analysis of purified gonadotropes from control and cKO males revealed a profound decrease in expression of gremlin (Grem1), a bone morphogenetic protein (BMP) antagonist. We show Grem1 was expressed in gonadotropes, but not other cell lineages, in the adult male mouse pituitary. Furthermore, Gata2, Grem1, and Fshb mRNA levels were significantly higher in the pituitaries of WT males relative to females but decreased in males treated with estradiol and increased following ovariectomy in control but not cKO females. Finally, we found that recombinant gremlin stimulated Fshb expression in pituitary cultures from WT mice. Collectively, the data suggest that GATA2 promotes Grem1 expression in gonadotropes and that the gremlin protein potentiates FSH production. The mechanisms of gremlin action have not yet been established but may involve attenuation of BMP binding to activin type II receptors in gonadotropes, facilitating induction of Fshb transcription by activins or related ligands.

Identifiants

pubmed: 35643321
pii: S0021-9258(22)00512-9
doi: 10.1016/j.jbc.2022.102072
pmc: PMC9251782
pii:
doi:

Substances chimiques

Bone Morphogenetic Proteins 0
Follicle Stimulating Hormone, beta Subunit 0
GATA2 Transcription Factor 0
Gata2 protein, mouse 0
Grem1 protein, mouse 0
Intercellular Signaling Peptides and Proteins 0
Activins 104625-48-1
Follicle Stimulating Hormone 9002-68-0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

102072

Subventions

Organisme : NIDDK NIH HHS
ID : R01 DK046943
Pays : United States
Organisme : CIHR
ID : PJT-162343
Pays : Canada
Organisme : CIHR
ID : -169184
Pays : Canada

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflict of interest The authors declare that they have no conflicts of interest with the contents of this article.

Auteurs

Gauthier Schang (G)

Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.

Luisina Ongaro (L)

Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.

Emilie Brûlé (E)

Department of Anatomy and Cell Biology, McGill University, Montréal, Québec, Canada.

Xiang Zhou (X)

Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.

Ying Wang (Y)

Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada.

Ulrich Boehm (U)

Department of Experimental Pharmacology, Center for Molecular Signaling, Saarland University School of Medicine, Homburg, Germany.

Frederique Ruf-Zamojski (F)

Department of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Michel Zamojski (M)

Department of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Natalia Mendelev (N)

Department of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Nitish Seenarine (N)

Department of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Mary Anne Amper (MA)

Department of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Venugopalan Nair (V)

Department of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Yongchao Ge (Y)

Department of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Stuart C Sealfon (SC)

Department of Neurology, Center for Advanced Research on Diagnostic Assays, Icahn School of Medicine at Mount Sinai, New York, New York, USA.

Daniel J Bernard (DJ)

Department of Pharmacology and Therapeutics, McGill University, Montréal, Québec, Canada; Department of Anatomy and Cell Biology, McGill University, Montréal, Québec, Canada. Electronic address: daniel.bernard@mcgill.ca.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH